Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics

Antiverse Ltd (Antiverse) and GlobalBio, Inc. (GlobalBio) today announced they will be extending their collaboration to advance immune checkpoint inhibitors in cancer therapy.

Twins and Dementia; CRISPR and Alzheimer’s; BTK Inhibitor Fails in MS Trials

Dementia in one twin raised the risk of a shorter lifespan of a co-twin without dementia. (Alzheimer’s and Dementia) Daily cocoa extract supplementation did not

December 13, 2023

FDA’s Janet Woodcock to retire early next year

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through

November 16, 2023

Mavacamten Shows Promise in Heart Failure With Normal to Supranormal EF

There may be a future for cardiac myosin inhibitors in heart failure with preserved ejection fraction (HFpEF), according to the proof-of-concept EMBARK-HFpEF trial. An established

October 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.